Cargando…
Letter to the Editor: Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use
Autor principal: | Ng, Alexander Clevewood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239592/ https://www.ncbi.nlm.nih.gov/pubmed/34222740 http://dx.doi.org/10.1002/hep4.1750 |
Ejemplares similares
-
Letter to the Editor: Reply to Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use
por: Efe, Cumali, et al.
Publicado: (2021) -
Reply to the Letter to the editor “Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD”
por: Takahashi, Hirokazu, et al.
Publicado: (2022) -
Letter to Editor
por: Saks, Michael J.
Publicado: (2021) -
Letter to Editor
por: Ditrich, Hans
Publicado: (2021) -
Letter to the Editor
por: Dharmadhikari, Ashwin S., et al.
Publicado: (2011)